Molecular Construct and Packaging Core

$134,080P30FY2016EYNIH

University Of California At Davis, Davis CA

Investigators

Linked publications & trials

Paper 39641747 Paper 39485362 Paper 39484372 Paper 39253497 Paper 39240185 Paper 39164392 Paper 38969634 Paper 38866538 Paper 38506851 Paper 38176611 Paper 38147763 Paper 37976328 Paper 37974363 Paper 37859806 Paper 37859506 Paper 37815029 Paper 37773500 Paper 37762630 Paper 37751417 Paper 37485736 Paper 37461461 Paper 37398269 Paper 37272771 Paper 37152673 Paper 36989037 Paper 36806671 Paper 36711950 Paper 36689233 Paper 36470430 Paper 36360232 Paper 36348026 Paper 36291655 Paper 36278870 Paper 36156731 Paper 36048012 Paper 36041786 Paper 35972433 Paper 35943734 Paper 35631569 Paper 35568989 Paper 35346188 Paper 35165951 Paper 35084084 Paper 34971485 Paper 34897697 Paper 34817116 Paper 34661622 Paper 34654439 Paper 34532411 Paper 34532408 Paper 34376700 Paper 34297915 Paper 34103362 Paper 34018720 Paper 33502442 Paper 33446041 Paper 33428890 Paper 33340512 Paper 33220237 Paper 33180748 Paper 33137194 Paper 33137037 Paper 32947393 Paper 32873638 Paper 32821518 Paper 32817515 Paper 32708020 Paper 32176260 Paper 32154443 Paper 32128346 Paper 32086286 Paper 32084273 Paper 32078198 Paper 32055646 Paper 31974658 Paper 31949107 Paper 31925402 Paper 31881719 Paper 31738895 Paper 31682846 Paper 31653921 Paper 31634437 Paper 31565523 Paper 31528657 Paper 31488610 Paper 31469406 Paper 31465366 Paper 31402219 Paper 31350349 Paper 31254332 Paper 31197108 Paper 31179615 Paper 31109958 Paper 31012062 Paper 30890724 Paper 30890522 Paper 30820148 Paper 30667376 Paper 30588515 Paper 30578787

Abstract

Molecular Construct and Packaging: is a new core directed by Marie Burns to provide molecular construct and viroid particle production, focused on producing tools needed for optogenetics and perturbation of gene expression in vision research. To facilitate the development of this core, the Dean of the Medical School has provided salary support for a highly experienced professional staff member (50% FTE for 1 year). 11 R01i investigators and two new faculty are anticipated to be moderate to extensive users.

View original record on NIH RePORTER →